Li X, Tang J, Mao Y. Incidence and risk factors of drug-induced liver injury. Liver Int. 2022;42:1999–2014

Article  PubMed  Google Scholar 

Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36:451–455

Article  PubMed  Google Scholar 

Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419–1425

Article  PubMed  Google Scholar 

De Valle MB, Av Klinteberg V, Alem N, Olsson R, Björnsson E. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006;24:1187–1195

Article  PubMed  Google Scholar 

Andrade RJ, Lucena MI, Fernández MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129:512–521

Article  PubMed  Google Scholar 

Vega M, Verma M, Beswick D, et al. The incidence of drug- and herbal and dietary supplement-induced liver injury: preliminary findings from gastroenterologist-based surveillance in the population of the state of delaware. Drug Saf. 2017;40:783–787

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suk KT, Kim DJ, Kim CH, et al. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol. 2012;107:1380–1387

Article  PubMed  Google Scholar 

Shen T, Liu Y, Shang J, et al. Incidence and etiology of drug-induced liver injury in Mainland China. Gastroenterology. 2019;156:2230–2241

Article  PubMed  Google Scholar 

Vuppalanchi R, Liangpunsakul S, Chalasani N. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States? Am J Gastroenterol. 2007;102:558–562

Article  PubMed  Google Scholar 

Breu AC, Patwardhan VR, Nayor J, et al. A multicenter study into causes of severe acute liver injury. Clin Gastroenterol Hepatol. 2019;17:1201–1203

Article  PubMed  Google Scholar 

Chang B, Li B, Huang A, et al. Changes of four common non-infectious liver diseases for the hospitalized patients in Beijing 302 hospital from 2002 to 2013. Alcohol. 2016;54:61–65

Article  PubMed  Google Scholar 

Tujios SR, Lee WM. Acute liver failure induced by idiosyncratic reaction to drugs: challenges in diagnosis and therapy. Liver Int. 2018;38:6–14

Article  PubMed  Google Scholar 

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. https://www.ncbi.nlm.nih.gov/books/NBK547852/. Accessed 1 Apr 2023

Mao Y. HepaTox: a professional website that promotes clincial and translational research of DILI in China. Gan Zang. 2014;8:575–576

Google Scholar 

Low EXS, Zheng Q, Chan E, Lim SG. Drug induced liver injury: east versus west—a systematic review and meta-analysis. Clin Mol Hepatol. 2020;26:142–154

Article  PubMed  Google Scholar 

Marzuki OA, Fauzi ARM, Ayoub S, Kamarul IM. Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia. Singap Med J. 2008;49:688–693

CAS  Google Scholar 

Chirapongsathorn S, Sukeepaisarnjaroen W, Treeprasertsuk S, et al. Characteristics of drug-induced liver injury in chronic liver disease: results from the Thai Association for the Study of the Liver (THASL) DILI Registry. J Clin Transl Hepatol. 2023;11:88–96

PubMed  Google Scholar 

Teo DCH, Ng PSL, Tan SH, et al. Drug-induced liver injury associated with complementary and alternative medicine: a review of adverse event reports in an Asian community from 2009 to 2014. BMC Complement Altern Med. 2016;16:192

Article  PubMed  PubMed Central  Google Scholar 

Huang Y-S, Tseng S-Y, Chen W-W, et al. Clinical characteristics and outcomes of drug-induced liver injury in Taiwan: with emphasis on the impact of chronic hepatitis B infection. J Chin Med Assoc. 2022;85:286–294

Article  CAS  PubMed  Google Scholar 

Devarbhavi H, Joseph T, Sunil Kumar N, et al. The Indian network of drug-induced liver injury: etiology, clinical features, outcome and prognostic markers in 1288 patients. J Clin Exp Hepatol. 2021;11:288–298

Article  CAS  PubMed  Google Scholar 

Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148(7):1340–1352

Article  PubMed  Google Scholar 

Hoofnagle JH, Björnsson ES. Drug-induced liver injury—types and phenotypes. N Engl J Med. 2019;381:264–273

Article  CAS  PubMed  Google Scholar 

Aithal GP, Watkins PB, Andrade RJ, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89:806–815

Article  CAS  PubMed  Google Scholar 

Wang Q, Huang A, Wang J-B, Zou Z. Chronic drug-induced liver injury: updates and future challenges. Front Pharmacol. 2021;12: 627133

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kleiner DE, Chalasani NP, Lee WM, et al. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology. 2014;59:661–670

Article  PubMed  Google Scholar 

EASL Clinical Practice Guidelines. Drug-induced liver injury. J Hepatol. 2019;70:1222–1261

Article  Google Scholar 

Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2021;116:878–898

Article  CAS  PubMed  Google Scholar 

Lammert C, Einarsson S, Saha C, Niklasson A, Bjornsson E, Chalasani N. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology. 2008;47:2003–2009

Article  CAS  PubMed  Google Scholar 

Carrascosa MF, Salcines-Caviedes JR, Lucena MI, Andrade RJ. Acute liver failure following atorvastatin dose escalation: is there a threshold dose for idiosyncratic hepatotoxicity? J Hepatol. 2015;62:751–752

Article  CAS  PubMed  Google Scholar 

Hughes JD, Blagg J, Price DA, et al. Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg Med Chem Lett. 2008;18:4872–4875

Article  CAS  PubMed  Google Scholar 

Chen M, Borlak J, Tong W. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology. 2013;58:388–396

Article  CAS  PubMed  Google Scholar 

Aleo MD, Luo Y, Swiss R, Bonin PD, Potter DM, Will Y. Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology. 2014;60:1015–1022

Article  CAS  PubMed  Google Scholar 

Tazuma S. Cyclosporin A and cholestasis: Its mechanism(s) and clinical relevancy. Hepatol Res. 2006;34:135–136

Article  CAS  PubMed  Google Scholar 

Morgan RE, Trauner M, van Staden CJ, et al. Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci. 2010;118:485–500

Article  CAS  PubMed  Google Scholar 

Yu K, Geng X, Chen M, et al. High daily dose and being a substrate of cytochrome P450 enzymes are two important predictors of drug-induced liver injury. Drug Metab Dispos. 2014;42:744–750

Article  PubMed  Google Scholar 

Zhuang X, Li L, Liu T, et al. Mechanisms of isoniazid and rifampicin-induced liver injury and the effects of natural medicinal ingredients: a review. Front Pharmacol. 2022;13:1037814

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rifadin IV (rifampin for injection USP). [package insert]. 2010. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/050420s073,050627s012lbl.pdf. Accessed 31 Oct 2023

Lucena MI, Sanabria J, García-Cortes M, Stephens C, Andrade RJ. Drug-induced liver injury in older people. Lancet Gastroenterol Hepatol. 2020;5:862–874

Article  PubMed  Google Scholar 

Gaude GS, Chaudhury A, Hattiholi J. Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients. J Fam Med Prim Care. 2015;4:238–243

Article  Google Scholar 

Weersink RA, Alvarez-Alvarez I, Medina-Cáliz I, et al. Clinical characteristics and outcome of drug-induced liver injury in the older patients: from the young-old to the oldest-old. Clin Pharmacol Ther. 2021;109:1147–1158

Article  CAS  PubMed  Google Scholar 

Andrade RJ, Aithal GP, de Boer YS, et al. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report. J Hepatol. 2023;79:853–866

Article  CAS  PubMed  PubMed Central